Company profile NVCR
There is not enough data for NovoCure -Medical Devices to provide analysis
There is not enough data for NovoCure -Medical Devices to provide correlation calculation
There is not enough data for NovoCure -Medical Devices to provide analysis
There is not enough data for Optune for glioblastoma to provide analysis
There is not enough data for Optune for glioblastoma to provide correlation calculation
There is not enough data for Optune for glioblastoma to provide analysis
There is not enough data for Optune Lua for malignant pleural mesothelioma to provide analysis
There is not enough data for Optune Lua for malignant pleural mesothelioma to provide correlation calculation
There is not enough data for Optune Lua for malignant pleural mesothelioma to provide analysis
There is not enough data for TTFields devices to provide analysis
There is not enough data for TTFields devices to provide correlation calculation
There is not enough data for TTFields devices to provide analysis
There is not enough data for tumor treating fields devices to provide analysis
There is not enough data for tumor treating fields devices to provide correlation calculation
There is not enough data for tumor treating fields devices to provide analysis
After 39 days of this quarter the interest is at 60.0. Based on that we can calculate that during remaining 52 days it will total up to 140.0. NovoCure Limited expected interest is significantly higher compared to same quarter last year (+677.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 99 | 51 -48.5% QoQ | 50 -2.0% QoQ | 91 82.0% QoQ |
| 2020 | 96 -3.0% YoY 5.5% QoQ | 150 194.1% YoY 56.2% QoQ | 160 220.0% YoY 6.7% QoQ | 45 -50.5% YoY -71.9% QoQ |
| 2021 | 134 39.6% YoY 197.8% QoQ | 125 -16.7% YoY -6.7% QoQ | 133 -16.9% YoY 6.4% QoQ | 52 15.6% YoY -60.9% QoQ |
| 2022 | 162 20.9% YoY 211.5% QoQ | 61 -51.2% YoY -62.3% QoQ | 140 5.3% YoY 129.5% QoQ | 83 59.6% YoY -40.7% QoQ |
| 2023 | 18 -88.9% YoY -78.3% QoQ | 77 26.2% YoY 327.8% QoQ | 40 -71.4% YoY -48.1% QoQ | 113 36.1% YoY 182.5% QoQ |
| 2024 | 60 233.3% YoY -46.9% QoQ | - | - | - |
The average 5 years interest of NovoCure Limited was 7.43 per week. The last year interest of NovoCure Limited compared to the last 5 years has changed by -24.9%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -0.36%.
There is not enough data for Novocure medical devices to provide analysis
There is not enough data for Novocure medical devices to provide correlation calculation
There is not enough data for Novocure medical devices to provide analysis
There is not enough data for NovoCure Oncology to provide analysis
There is not enough data for NovoCure Oncology to provide correlation calculation
There is not enough data for NovoCure Oncology to provide analysis
After 39 days of this quarter the interest is at 141.0. Based on that we can calculate that during remaining 52 days it will total up to 329.0. NovoCure Optune expected interest is significantly higher compared to previous quarter (+545.1%) and same quarter last year (+422.2%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 172 inf% QoQ | 189 9.9% QoQ | 118 -37.6% QoQ |
| 2020 | 113 inf% YoY -4.2% QoQ | 49 -71.5% YoY -56.6% QoQ | 86 -54.5% YoY 75.5% QoQ | 115 -2.5% YoY 33.7% QoQ |
| 2021 | 23 -79.6% YoY -80.0% QoQ | 137 179.6% YoY 495.7% QoQ | 256 197.7% YoY 86.9% QoQ | 58 -49.6% YoY -77.3% QoQ |
| 2022 | 46 100.0% YoY -20.7% QoQ | 23 -83.2% YoY -50.0% QoQ | 92 -64.1% YoY 300.0% QoQ | 165 184.5% YoY 79.3% QoQ |
| 2023 | 63 37.0% YoY -61.8% QoQ | 188 717.4% YoY 198.4% QoQ | 125 35.9% YoY -33.5% QoQ | 51 -69.1% YoY -59.2% QoQ |
| 2024 | 141 123.8% YoY 176.5% QoQ | - | - | - |
The average 5 years interest of NovoCure Optune was 8.47 per week. The last year interest of NovoCure Optune compared to the last 5 years has changed by 28.93%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -4.04%.
There is not enough data for NovoCure treatments to provide analysis
There is not enough data for NovoCure treatments to provide correlation calculation
There is not enough data for NovoCure treatments to provide analysis